Download PDF
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Evaluation of the transition from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease
Carmen Amor Costa; Cristina Suárez Ferrer; Laura García Ramírez; Eduardo Martín-Arranz; Joaquín Poza Cordón; José Luis Rueda García; María Sánchez Azofra; Irene González Diaz; Clara Amiama Roig; María Dolores Martín-Arranz;
Gastroenterol Hepatol. 2025;48:
Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11)
Natalia García Morales; Sagrario Gutiérrez Morato; Carmen Castillo Cejas; Margarita Fernández de la Varga; Martín Menéndez Rodríguez; Victoria Aguilera; Salvador Benlloch; Luis Menéndez Rodríguez; Teresa Seoane Pillado; Joaquín Cubiella;
Gastroenterol Hepatol. 2025;48:
Thromboembolic phenomena in inflammatory bowel disease and risk with JAK inhibitor treatments
José Luis Rueda García; José Manuel Benitez; Iria Baston Rey; Margalida Calafat Sard; Cristina Suárez Ferrer;
Gastroenterol Hepatol. 2025;48: